Medora Health patient guides
Explore patient guides on hospitals, treatments, clinical trials, costs, insurance, and planning each stage of medical care in China.
Explore patient guides on hospitals, treatments, clinical trials, costs, insurance, and planning each stage of medical care in China.
China Healthcare Guides
- Bringing Prescription Medicines to China for a Medical Trip
- Community Health Centres vs Tertiary Hospitals in China
- Expert Clinics, VIP Clinics and International Departments in China
- General vs Specialist Hospitals in China: Which Fits Your Care?
- Hospital Registration in China: A Step-by-Step Guide
- How International Patients Can Book a Specialist in China
- How Medical Referrals Work in China
- How to Choose the Right City in China for Medical Treatment
- How to Organise Medical Records Before Seeking Care in China
- How to Prepare for a Remote Consultation With a Doctor in China
- How to Request English-Language Medical Records in China
- How to Share CT, MRI and Other Imaging Files With a Chinese Hospital
- Informed Consent Across Languages: Questions Patients Should Ask
- Medical Interpretation in China: What International Patients Need
- Pathology and Laboratory Record Review Before Treatment in China
- Protecting Your Medical Privacy When Sharing Records Internationally
- Public vs Private Hospitals in China: What International Patients Should Know
- Seeking Medical Care in Beijing: A Practical Guide for International Patients
- Seeking Medical Care in Guangzhou: A Guide for International Patients
- Seeking Medical Care in Shanghai: A Guide for International Patients
- Seeking Medical Care in Shenzhen: A Guide for International Patients
- Understanding China’s Three-Tier Hospital System
- Using Hospital Apps and WeChat During Medical Care in China
- What a Medical Care Coordinator Can—and Cannot—Do
- What to Expect at a Chinese Hospital Outpatient Appointment
Clinical Trials & Advanced Treatments
- Adverse Event Reporting in Clinical Trials: A Patient Guide
- Antibody-Drug Conjugates: Treatment and Clinical Trial Questions
- Artificial Intelligence in Medical Imaging: What Patients Should Know
- Bispecific Antibodies in Cancer Care: A Patient Guide
- Cancer Vaccine Trials: What the Research Is Testing
- CAR-T Cell Therapy in China: Approved Care vs Clinical Trials
- Cell Therapy Manufacturing and Quality: Why It Matters
- Clinical Trial Costs, Travel, and Follow-Up Responsibilities
- Clinical Trial Eligibility: Why Patients May or May Not Qualify
- Clinical Trial Phases Explained for Patients
- Gene Therapy in China: Approved Uses, Trials, and Red Flags
- How to Find a Clinical Trial in China
- How to Verify a Research Hospital and Clinical Trial
- Informed Consent for Clinical Trials in China
- Liquid Biopsy in Cancer Care: Uses, Limits, and Clinical Trials
- Long-Term Follow-Up After Cell or Gene Therapy
- MR-Guided Radiotherapy: How Real-Time Imaging Supports Treatment
- New Alzheimer’s Drugs and Clinical Trials: Interpreting the 2026 Developments
- New DLBCL treatments and clinical trials: evidence that can change a decision
- New drugs and clinical trials for Hodgkin lymphoma: separating established evidence from research
- New Drugs and Clinical Trials for Mantle Cell Lymphoma: Understanding the 2026 Updates
- New drugs and trials for aplastic anemia: interpreting progress and checking eligibility
- New Drugs, Brain–Computer Interfaces and Clinical Trials in Stroke Rehabilitation
- New GVHD treatments and clinical trials: making sense of the 2026 developments
- New multiple sclerosis medicines and clinical trials: interpreting developments in 2026
- New myeloma drugs and clinical trials: evaluating options in China in 2026
- New Parkinson’s drugs and clinical trials in 2026: evidence, limitations and preparing for assessment in China
- New T-cell lymphoma drugs and trials in 2026: turning a research update into a verifiable option
- New thalassemia medicines and clinical trials in 2026: separating approvals, research, and personal eligibility
- New treatments and clinical trials for drug-resistant epilepsy: interpreting the 2026 developments
- New treatments and trials for follicular lymphoma: matching the evidence to your situation
- Oncolytic Virus Therapy Trials: Evidence, Risks, and Eligibility
- Precision Oncology Trials in China: Biomarkers and Matching
- Proton and Carbon-Ion Therapy in China: A Patient Guide
- Regenerative Medicine Claims: Questions Patients Should Ask
- Robotic Surgery in China: Benefits, Limits, and Surgeon Experience
- Sickle Cell New Treatments and Clinical Trials: 2026 Progress, Evidence Limits, and Participation
- Stem Cell Treatment: How to Distinguish Evidence From Marketing
- TCR-T Cell Therapy Trials: What Patients Should Understand
- What Happens After a Clinical Trial Ends? Post-Trial Access and Follow-Up
Cost & Insurance Guides
- A Contingency Budget for China Medical Travel: Fund the Failure Branches
- A Refund Is a Workflow: Cancel Medical Travel Without Losing the Paper Trail
- Alzheimer's Treatment Costs in China: Building a Budget for Assessment, Medicines, and Care
- Aplastic anemia treatment costs in China: build an itemized renminbi budget
- Before You Sign a China Treatment Agreement: 23 Financial Questions That Change the Deal
- China Treatment Reimbursement: Build a Claim File That Proves the Episode
- Comparing China Hospital Quotes: Normalize the Care Before the Price
- Direct Billing or Pay-and-Claim in China: Choose the Failure You Can Manage
- DLBCL treatment costs in China: building an itemized yuan budget
- Flights and Accommodation for China Medical Travel: Budget for Schedule Change
- Follicular lymphoma treatment costs in China: budgeting for assessment, the course and continuing care
- Food, Local Transport and Companion Costs in China: Budget by Day Type
- GVHD treatment costs in China: building an itemized RMB estimate
- Hodgkin lymphoma treatment costs in China: obtaining a comparable RMB quotation
- Hospital Deposits and Refunds in China: Follow the Money to Closure
- How to Request an Itemized Treatment Estimate in China
- Medical Interpreter and Patient Coordinator Fees in China: Buy the Right Role
- Medical Tourism Complication Insurance: Stress-Test the Rescue Plan
- Multiple myeloma treatment costs in China: obtaining a comparable, staged estimate
- Multiple sclerosis treatment costs in China: building a useful personal estimate
- Parkinson’s Treatment Costs in China: Medication, DBS and the Expenses After Treatment
- Paying a China Hospital: Build a Payment Route That Can Survive Failure
- Preauthorization for Treatment in China: Make Approval Match the Actual Plan
- Reading a Hospital Bill in China: From Deposit to Final Receipt
- Recovery Accommodation After Treatment in China: Estimate by Exit Criteria
- Sickle Cell Disease Treatment Costs in China: Checking Medicines, Transfusions, and Transplant Budgets
- Stroke Rehabilitation Costs in China: Building an Itemized RMB Budget
- The Price-Claim Autopsy: Test a Medical Tourism Offer Before It Tests You
- What does drug-resistant epilepsy treatment cost in China? Building a usable estimate
- What Does Mantle Cell Lymphoma Treatment Cost in China? Building an Itemized Renminbi Budget
- What does T-cell lymphoma treatment cost in China? Building an estimate that can be compared and updated
- What does thalassemia treatment cost in China? Building a budget for transfusion, chelation, transplantation, and follow-up
- When the Return Date Breaks: An Extended-Stay Playbook for Medical Care in China
- Why the Estimate Changed After Evaluation: Audit the Clinical Delta
- Will International Health Insurance Pay for Treatment in China?
Hospital Guides
- Choosing a China hospital for DLBCL: match the center to the clinical task
- Choosing a follicular lymphoma hospital in China: match the team to the decision you need
- Choosing a GVHD hospital in China: transplant follow-up and organ-specific care
- Choosing a Hodgkin lymphoma hospital in China: matching first-line, radiation, and relapse needs
- Choosing a Hospital in Beijing: Specialties, Access, and Travel
- Choosing a Hospital in Chengdu: Three Distances, Two Airports, and a Safe Recovery Radius
- Choosing a hospital in China for aplastic anemia: diagnosis, medical treatment, and donor transplantation
- Choosing a hospital in China for drug-resistant epilepsy: match the center to the clinical problem
- Choosing a Hospital in China for Mantle Cell Lymphoma: Specialist Review and Continuity of Care
- Choosing a hospital in China for multiple myeloma: match the team to the treatment phase
- Choosing a hospital in China for multiple sclerosis: matching the team to the full course of care
- Choosing a Hospital in China for Sickle Cell Disease: Expertise, Blood Support, and Continuing Care
- Choosing a hospital in China for T-cell lymphoma: questions about subtype expertise, pathology and continuity
- Choosing a Hospital in Guangzhou: Specialties, Access, and Travel
- Choosing a Hospital in Hainan: Five Island Filters for Treatment and Recovery
- Choosing a Hospital in Hangzhou: Three Proofs and One Real-world Test
- Choosing a Hospital in Nanjing: Clinical Dependencies, River Crossings, and Campus Access
- Choosing a Hospital in Shanghai: Specialties, Access, and Travel
- Choosing a Hospital in Shenzhen: Clinical Fit, Cross-border Boundaries, and Travel
- Choosing a Hospital in Tianjin: Specialty Fit, Campus Geography, and the Beijing Question
- Choosing a Hospital in Wuhan: Four Clocks Across the Three Towns
- Choosing a Parkinson’s Hospital in China: Diagnosis, Procedures and Support at Home
- Choosing a Stroke Rehabilitation Hospital in China: Match the Team to Your Needs
- Choosing a thalassemia hospital in China: match the service to the problem you need solved
- Choosing an Alzheimer's Hospital in China: Memory Assessment, Antibody Treatment, and Care Support
- Discharge Coordination and Overseas Follow-Up from a Chinese Hospital: “Sent” Is Not “Received”
- Hospital Insurance, Billing, and Payment Support for Foreign Patients in China: Reconcile Three Ledgers
- Hospital Quality Signals International Patients Should Review
- How to Choose a Cancer Hospital in China: Audit the Whole Treatment Chain
- How to Choose a Fertility Centre in China: Read the Denominator Before the Success Rate
- How to Choose a Heart Hospital or Cardiology Centre in China: Start with the 2 a.m. Door
- How to Choose a Hospital in China: A Guide for International Patients
- How to Choose a Rehabilitation Hospital in China: Follow the Patient’s Whole Day
- How to Choose an Orthopaedic or Spine Hospital in China: Function Before Hardware
- How to Compare Hospital Second Opinions in China
- How to Verify a Hospital, Department, and Doctor in China
- International Patient Admission Services in Chinese Hospitals: Get Four Confirmations Before You Fly
- Language Support and English Medical Records at Chinese Hospitals: Three Different Products
- Private Rooms, VIP Wards, and International Clinics in China: Do Not Confuse Comfort with Capability
- What Makes a Strong International Medical Department?
Patient Education & FAQ
- 20 Questions About Parkinson’s Treatment: Medicines, DBS, New Therapies and Care in China
- 20 Questions About Sickle Cell Disease: Medicines, Transfusion, Gene Therapy, and Care in China
- A Personal Medical-Travel Safety Plan That Still Works When Something Changes
- After Surgery Away From Home: Which Warning Signs Need 120, Same-Day Surgical Contact or Monitoring?
- Alzheimer’s Disease Prognosis: Treatment Outcomes, Daily Function and Future Care
- Alzheimer's Stages and Risk: Why Younger Onset, Early Disease, and MCI Differ
- Antibiotics Are Not a Measure of How “Serious” an Infection Is
- Aplastic anemia prognosis: response, relapse, and long-term recovery
- Aplastic anemia types and risk: what nonsevere, severe, and very severe mean
- Before You Accept an Overseas Treatment Plan: Questions That Change the Decision
- Benefits, Risks and Alternatives: How to Make Medical Numbers Mean Something
- Blood Tests Before Treatment: Why They Are Repeated, Whether to Fast and How Results Change the Plan
- Blood Transfusion Safety: Decide the Need, Match the Component and Monitor the Patient
- Blood-Clot Prevention During Medical Travel: Join the Hospital Plan to the Journey Home
- Can DLBCL be cured? Understanding response, relapse and prognosis
- Can Hodgkin lymphoma be cured? Making sense of remission, survival, and relapse risk
- Chest Pain While Traveling: Stop the Journey and Start Local Emergency Care
- Classifying drug-resistant epilepsy and assessing risk: separate seizure type, syndrome, cause, and treatment response
- CT in China: Radiation, Iodinated Contrast and the Exact Scan Protocol to Confirm
- Diagnosing aplastic anemia: essential tests and targeted investigations
- DLBCL patient FAQ: 20 questions about treatment, relapse and care in China
- DLBCL types and risk: distinguishing disease biology from treatment fitness
- Family Caregivers in International Care: Be the Safety Net, Not the Whole System
- Fever Before or After Treatment: The Number Matters, but the Context Decides the Urgency
- Follicular lymphoma prognosis: interpreting survival, remission and the course ahead
- Follicular lymphoma types and risk: separating grade, stage, FLIPI and early progression
- Food and Water During Recovery in China: Safe Enough for This Patient, This Week
- General Anesthesia Without the Mystique: What Happens From Induction to the Recovery Room
- Genetic or Genomic Test? First Decide Whether the Question Is Inherited Risk, Diagnosis or Treatment
- GVHD Types and Risk: Acute, Chronic, Overlap, and Steroid-Refractory Disease
- Herb–Drug Interactions: “Natural” Is Not a Medication Category
- Hodgkin Lymphoma: 20 Patient Questions About Diagnosis, Treatment, and Care in China
- Hospital Hand Hygiene: Patients Can Ask Without Policing the Ward
- How Long Can Mantle Cell Lymphoma Be Controlled? Understanding Remission, Survival, and Your Prognosis
- How long can remission last in T-cell lymphoma? Understanding prognosis and survival figures
- How long can someone with thalassemia live? Understanding prognosis, treatment outcomes, and everyday life
- How Much Recovery Is Possible After Ischemic Stroke? Understanding Prognosis and Progress
- How Stroke Rehabilitation Needs Differ: Cause, Disability and Risk
- Mantle cell lymphoma types and risk: understanding indolent behavior, high-risk biology and stage
- Mantle Cell Lymphoma: 20 Questions About Diagnosis, Treatment in China, and Returning Home
- Medical Emergencies During Travel in China: What to Do
- Medical Travel for Older Adults: Plan Around Function, Not the Birth Date
- Medical Travel With Diabetes: Keep the Treatment Clock Running
- Medical Travel With Heart Disease: Stability Has to Survive the Itinerary
- Medical Travel With High Blood Pressure: Bring a Reliable Trend, Not One Anxious Reading
- Medical Travel With Kidney Disease: The Flight Is the Short Part of the Plan
- Medical Travel With Limited Mobility: Plan Every Transfer, Not Just the Flight
- MRI in China: The Implant Card, Contrast Decision and Claustrophobia Plan to Settle Before Scan Day
- Multiple myeloma outcomes: interpreting survival figures and planning for recovery
- Multiple myeloma types and risk: understanding the different labels
- One-Page Medical Summary for Overseas Care: Make the First Minute Count
- Pain Medicine After Surgery: Control Pain Without Hiding a Complication
- Parkinson’s disease outcomes and prognosis: independence, long-term risks and planning ahead
- Parkinson's Disease Types: How Age at Onset, Tremor, and Gait Problems Affect Care
- PET/CT for Cancer Care: The Tracer, Timing and Limitations Behind a “Hot Spot”
- Possible Stroke During Medical Travel: Use BE-FAST, Note the Last-Known-Well Time, Call 120
- Preoperative Assessment Is Not a Rubber Stamp: It Builds the Safest Achievable Plan for Surgery
- Preventing Surgical Site Infection: The Questions Patients Can Ask Before and After an Operation
- Prognosis in drug-resistant epilepsy: seizure freedom, meaningful improvement and long-term review
- Protecting a Surgical Wound While Traveling: A Plan for the Journey, Not Just the Dressing
- Reading a follicular lymphoma report: what pathology, PET and blood results can tell you
- Reading a mantle cell lymphoma report: Cyclin D1, SOX11, Ki-67 and TP53 explained
- Reading T-cell lymphoma reports: connecting pathology, PET scans and blood results
- Reading thalassemia reports: distinguish the inherited diagnosis, anemia, iron burden, and organ health
- Recovery and Prognosis After GVHD: Understanding Response, Treatment-Free Time and Daily Function
- Respiratory Infection Prevention During Medical Travel: Protect the Treatment Window
- Sickle Cell Genotypes and Risk: Understanding HbSS, HbSC, and Sickle Beta Thalassemia
- Testing for Sickle Cell Disease: From a Screening Result to a Confirmed Diagnosis
- Tests Before Stroke Rehabilitation: Medical Review, Functional Assessment and Preparation
- Tests for drug-resistant epilepsy: confirm the events, investigate the cause, and define treatment options
- Tests for follicular lymphoma: choosing a biopsy, establishing stage and preparing safely for treatment
- Tests for Suspected ALS: What Examination, EMG, Imaging, and Genetics Can Establish
- Tests for Suspected Alzheimer's Disease: What a Memory Clinic Needs to Establish
- Tests for suspected DLBCL: biopsy, staging and preparation for treatment
- Tests for suspected Hodgkin lymphoma: biopsy, staging, and treatment preparation
- Tests for suspected multiple myeloma: what each step is meant to establish
- Tests for suspected multiple sclerosis: preparing for MRI, spinal-fluid testing, and specialist review
- Tests for Suspected Parkinson's Disease in China: What Each Assessment Can Establish
- Tests for suspected T-cell lymphoma: obtaining the right tissue and a usable diagnosis
- Tests for suspected thalassemia: moving from a blood count to hemoglobin and genetic confirmation
- Thalassemia types and risk: why people with the same broad diagnosis need different care
- Traveling With Prescription Medicines: Build a Legal, Temperature-Safe and Clinically Usable Medication Plan
- Twenty patient questions about aplastic anemia, treatment, and care in China
- Twenty patient questions about GVHD: treatment, tapering, care in China, and follow-up
- Twenty patient questions about ischemic stroke rehabilitation and care in China
- Twenty patient questions about T-cell lymphoma: diagnosis, treatment and daily decisions
- Twenty Questions About Myelodysplastic Syndrome: Diagnosis, Transfusions, Medicines, Transplant and Care in China
- Twenty Questions Families Ask About Alzheimer's Disease and Care in China
- Twenty questions patients ask about drug-resistant epilepsy and treatment in China
- Twenty questions patients ask about follicular lymphoma and care in China
- Twenty Questions Patients Ask About Multiple Myeloma Treatment in China
- Twenty thalassemia questions: diagnosis, treatment, and planning care in China
- Types and risk groups of Hodgkin lymphoma: what changes treatment
- Types of multiple sclerosis and personal risk: what relapses and progression change
- Types of T-cell lymphoma: why subtype, stage and risk describe different things
- Understanding a DLBCL report: pathology, FISH, IPI and PET findings
- Understanding a GVHD Report: Organ Scores, Pathology, and Transplant Results
- Understanding a Hodgkin lymphoma report: pathology, stage, and Deauville score
- Understanding a multiple myeloma report: protein, marrow, imaging, and MRD
- Understanding a Parkinson's Assessment Report: Scores, Imaging, and Biomarker Results
- Understanding a Stroke Rehabilitation Report: Imaging, Scores and Assistance Needs
- Understanding Alzheimer's Test Reports: Cognitive Scores, Atrophy, p-tau, and APOE
- Understanding an aplastic anemia report: hypocellularity, PNH clones, and genetic findings
- Understanding an MS report: MRI lesions, spinal-fluid results, and functional measurements
- Understanding drug-resistant epilepsy reports: EEG findings, MRI lesions, and the final presurgical opinion
- Understanding multiple sclerosis prognosis: survival, independence and treatment response
- Understanding Sickle Cell Reports: Hemoglobin, HbS, HbF, Reticulocytes, and Iron Measurements
- What Outcomes Are Possible with Sickle Cell Disease? Understanding Survival, Treatment Response, and Personal Prognosis
- When Two Pathology Reports Differ: Reconcile the Specimen, Methods and Diagnosis Before Treatment
- Which tests diagnose mantle cell lymphoma? Understanding biopsy, PET/CT, bone marrow and gene testing
- Which Tests Help Diagnose Graft-Versus-Host Disease After Transplantation?
Patient Journey Guides
- Accommodation Near a Chinese Hospital: Test the Recovery Route, Not the Map Pin
- After Medical Travel: Build a Complication Plan That Works Under Stress
- After stroke rehabilitation in China: Continuing care and recovery at home
- Alzheimer's Follow-up After Care in China: Making the Return-Home Plan Work
- An Inpatient Stay in China: Build a Daily Control Board at the Bedside
- Before a Procedure in China: Audit the Decision, Not Just the Signature
- Can Someone with Parkinson’s Travel to China for Treatment? Readiness, Medicines and Care During the Journey
- DLBCL follow-up after returning home: surveillance, recovery and handover
- Documents for Treatment in China: Build a Decision-Ready Case Packet
- Flights Before and After Treatment in China: Four Clearances, Not One Date
- Flying After Surgery or Treatment: Clearance Is a Risk Profile, Not a Date
- Follicular lymphoma follow-up after returning home from China
- Follow-up after drug-resistant epilepsy treatment in China: keeping care connected at home
- Follow-up after GVHD treatment in China: connecting tests, prescriptions, and organ care at home
- Follow-Up After Multiple Sclerosis Care in China: Connecting Results to Decisions
- Follow-up after returning home from T-cell lymphoma treatment: coordinating tests, medicines and new symptoms
- Follow-up after thalassemia care in China: assign each next step to a clinician who can carry it out
- Follow-up at home after aplastic anemia treatment in China
- Handing Care to Your Doctor at Home: “Received” Is Not “Accepted”
- Hospital Admission in China: Know When the Bed, Account and Clinical Responsibility Become Real
- Hospital Deposits in China: Match the Payer, Patient Account and Refund Route
- Hospital Discharge in China: Do Not Leave Until Six Closure Chains Agree
- Identity Checks at a Chinese Hospital: Keep One Patient Attached to One Story
- Is Travel to China Appropriate for Multiple Sclerosis Care? Planning Around Your Treatment
- Medical Interpreters in Appointments: Keep the Conversation Between Patient and Clinician
- Medical records for a DLBCL consultation in China: a practical preparation guide
- Medical records for a drug-resistant epilepsy consultation in China: make the history understandable
- Medical records for a GVHD consultation in China: connect the transplant history, organ changes, and treatment response
- Medical records for an aplastic anemia referral: making the evidence usable
- Medical Records for an MDS Consultation in China: Marrow Reports, Genetics, Transfusions and Treatment History
- Medical Records for an MS Consultation in China: Showing How the Disease Has Changed
- Medical records for myeloma care in China: documenting diagnosis, resistance and treatment readiness
- Medical Records for Parkinson’s Care in China: Showing Symptoms, Medication Response and Previous Procedures
- Medical Records for Sickle Cell Care in China: Diagnosis, Blood Compatibility, Crises, and Treatment History
- Medical records for thalassemia care in China: build a usable history of diagnosis, transfusions, iron, and treatment
- Medical Records to Take Home from China: Build an Evidence Pack with Provenance
- Medical Travel to China: A 12-Week Planning Timeline
- Medication Reconciliation Before Leaving China: Make Every Dose Survive the Border
- Myeloma follow-up after treatment in China: tests, prescriptions and continuing care at home
- Nutrition During Hospital Recovery: Choose the Route Before Counting Calories
- Pain After a Procedure: Set a Function Target and a Rescue Boundary
- Parkinson’s Follow-up After Treatment in China: Prescriptions, Devices and Everyday Function at Home
- Preparing Alzheimer's Medical Records for a Consultation in China
- Preparing follicular lymphoma records for care in China
- Preparing Mantle Cell Lymphoma Records for a Consultation in China
- Preparing records for stroke rehabilitation in China: Imaging, medicines and function
- Preparing T-cell lymphoma records for referral: documenting the diagnosis and each treatment line
- Records for a Hodgkin lymphoma consultation in China: pathology, PET images, and treatment actually given
- Recovering in a Hotel After Treatment: Make the Room Pass a Clinical Use Test
- Rehabilitation Before Returning Home: Transfer Function, Not Exercise Names
- Remote Follow-Up with a China Medical Team: Build a Three-Party Control Loop
- Repeating Tests After Arrival: Ask What Decision the New Result Will Change
- Returning Home After Hodgkin Lymphoma Treatment in China: Follow-up That Continues Across Borders
- Returning Home After Mantle Cell Lymphoma Treatment in China: Making Follow-Up Work
- Returning Home After MDS Treatment in China: Follow-Up Tests, Transfusions, Prescriptions and Transplant Care
- Should a patient with DLBCL travel to China for treatment?
- Should a patient with multiple myeloma travel to China for treatment?
- Should I travel to China for Hodgkin lymphoma care? Referral value and medical readiness
- Should Someone Accompany You for Treatment in China? Write the Job Description First
- Should Someone With Alzheimer's Disease Travel to China for Care?
- Should someone with drug-resistant epilepsy travel to China for care?
- Should you travel to China for aplastic anemia treatment?
- Should you travel to China for follicular lymphoma care?
- Should you travel to China for GVHD treatment? Define the benefit and the care needed around the journey
- Should You Travel to China for Mantle Cell Lymphoma Care? Purpose, Stability, and Treatment Continuity
- Should You Travel to China for Myelodysplastic Syndrome Treatment? Defining the Benefit Before Booking
- Should you travel to China for thalassemia care? Assess the purpose and the conditions for a safe journey
- Sickle Cell Follow-up After Treatment in China: Medicines, Transfusions, Monitoring, and Urgent Care
- Surgery Day in China: Follow the Handoffs, Not a Promised Clock Time
- Vaccination Before Medical Travel to China: Protect the Treatment Window
- Visa Planning for Treatment in China: Two Approvals, Four Dates
- Warning Signs During Recovery: Read the Change, Not Just the Number
- What to Pack for Hospital Treatment in China: Pack by Failure Consequence
- Who should consider travelling to China for T-cell lymphoma care? Clarifying referral value and travel readiness
- Who Should Travel to China for Sickle Cell Care? Clinical Benefit, Stability, and Receiving Arrangements
- Who should travel to China for stroke rehabilitation? Assessing need and travel readiness
- Your First 24 Hours in China: Make Every Handoff Visible
- Your First Hospital Appointment in China: Leave With a Decision Record
Treatment Guides
- Acupuncture in China: Evidence, Safety, and Choosing a Provider
- After an Alzheimer's Diagnosis: Building the First Treatment Plan
- ALS Treatment in China: Medicines, Breathing Support, and Everyday Care
- Alzheimer’s Disease Medication: Cognitive Symptoms, Antibodies and Treatment of Agitation
- Alzheimer’s Getting Worse Despite Treatment: What Should Happen Next?
- Alzheimer's Treatment Side Effects: Recognizing Problems and Getting the Right Help
- Aplastic anemia treatment: from immediate protection to lasting marrow recovery
- Arrhythmia Evaluation and Catheter Ablation in China
- Brain Tumor Surgery in China: Multidisciplinary Treatment Planning
- Building the Initial Rehabilitation Plan After Ischemic Stroke
- Cancer Immunotherapy in China: Questions to Ask Before Treatment
- Cancer Rehabilitation: Managing Function, Fatigue, and Recovery
- Cancer Surgery in China: How to Prepare and Compare Options
- Cardiac Rehabilitation After Heart Treatment
- Checking Sickle Cell Medicines: Hydroxyurea, Regulatory Updates, Pain Relief, and Monitoring
- Chemotherapy in China: Planning, Safety, and Follow-Up
- Chinese Herbal Medicine Safety: Interactions and Quality Questions
- Choosing first treatment for T-cell lymphoma: diagnosis, regimen and response planning
- Choosing first-line Hodgkin lymphoma treatment: a practical decision guide
- Choosing first-line treatment for DLBCL and preparing for the first cycle
- Choosing first-line treatment for mantle cell lymphoma: questions to settle before the first cycle
- Choosing Stroke Rehabilitation Methods: Task Practice, Robotics, Virtual Reality and Home Care
- Choosing the first MS treatment: turning an initial prescription into a workable plan
- Comparing Alzheimer's Treatments: Symptom Medicines, Lecanemab, and Donanemab
- Comparing aplastic anemia treatments: making a decision between transplant and immunosuppression
- Comparing DLBCL treatments: which options belong at which stage?
- Comparing drug-resistant epilepsy treatments: medicines, resection, ablation, stimulation, and dietary therapy
- Comparing follicular lymphoma treatments: which choices address the same problem?
- Comparing GVHD Treatments: What Steroids, Targeted Medicines, Photopheresis and Cell Products Can Offer
- Comparing Hodgkin lymphoma regimens: ABVD, N-AVD, BV-AVD, and BrECADD
- Comparing mantle cell lymphoma treatments: chemoimmunotherapy, BTK combinations and autologous transplant
- Comparing MS treatment plans: medicines, transplantation, rehabilitation, and the outcomes that matter
- Comparing multiple myeloma treatments: match the stage and resistance history
- Comparing Parkinson's Treatments: Medication Adjustment, Infusion, DBS, and Focused Ultrasound
- Comparing Sickle Cell Treatments: Medicines, Transfusion, Transplantation, and Gene Therapy
- Comparing T-cell lymphoma treatments: what drug lists and response rates leave out
- Comparing thalassemia treatments: blood support, anemia medicines, transplantation, and gene therapy
- Coronary Angiography in China: What Patients Can Expect
- Coronary Artery Bypass Surgery in China: Planning Your Care
- Deep brain stimulation for Parkinson’s disease: assessment, surgery and follow-up after treatment in China
- Deep Brain Stimulation: Candidacy, Surgery, and Follow-Up
- Dental Crowns and Bridges: Materials, Treatment, and Aftercare
- Dental Implants in China: Planning Safe Treatment Abroad
- Discomfort and Treatment Risks During Stroke Rehabilitation: When to Adjust or Seek Help
- DLBCL medicines: drug classes, combinations and safe medication records
- DLBCL treatment side effects: daily management and urgent symptoms
- Do I need radiation after Hodgkin lymphoma chemotherapy? From PET results to a treatment plan
- Does DLBCL need surgery? Biopsy, vascular access and urgent procedures
- Does GVHD Require Surgery? Understanding Biopsies, Dilation, Eye Procedures and Treatment Access
- Does Hodgkin lymphoma need surgery? Biopsy, venous access, and stem cell collection
- Does mantle cell lymphoma need surgery? Biopsy, venous access, cell collection and emergency procedures
- Does T-cell lymphoma need surgery? Biopsy, vascular access, bowel procedures and cell collection
- Drug-resistant epilepsy surgery: preparing for evaluation, consent, the procedure and recovery
- Drug-resistant epilepsy treatment: what to do when two suitable medication schedules have not controlled seizures
- Endometriosis Treatment in China: Diagnosis, Surgery and Follow-Up
- Epilepsy Evaluation and Surgery: Understanding the Care Pathway
- Extracorporeal Photopheresis for GVHD: The Procedure, Repeated Visits and Response Assessment
- Fertility Assessment in China: Tests, Timelines and Questions
- First-line treatment for follicular lymphoma: defining the reason to start and choosing a workable regimen
- First-line treatment for severe aplastic anemia: transplantation or ATG-based therapy
- Focused ultrasound and lesion procedures for Parkinson’s disease: targets, bilateral risks and treatment in China
- Follicular lymphoma treatment side effects: recognizing problems and knowing when to seek help
- Follicular lymphoma treatment: deciding when to act and what the first plan should achieve
- Follow-Up Care After Cancer Treatment in China
- Full-Mouth Rehabilitation in China: A Patient Guide
- Getting a Cancer Second Opinion in China
- Getting a Neurosurgery Second Opinion in China
- Gynecologic Cancer Treatment in China: Planning Multidisciplinary Care
- Heart Valve Repair and Replacement: Comparing Treatment Options
- Hip Replacement in China: Surgery, Recovery, and Travel
- Hodgkin lymphoma treatment: decisions from diagnosis to recovery
- How is mantle cell lymphoma treated? A practical guide from observation to treatment after relapse
- How long aplastic anemia treatment takes: admission, response, tapering, and return home
- How long DLBCL treatment takes: cycles, assessment and time away from home
- How Long Does Alzheimer's Treatment Last? Reviews, Antibody Therapy, and Planning Care in China
- How long does drug-resistant epilepsy treatment take? Planning medication, procedures, and withdrawal
- How long does follicular lymphoma treatment take? Monitoring, induction, maintenance and recovery
- How long does GVHD treatment take? Planning admission, response assessment, tapering, and return travel
- How long does Hodgkin lymphoma treatment take? Cycles, PET checkpoints, radiation, and travel
- How Long Does Mantle Cell Lymphoma Treatment Take? Cycles, Maintenance, and Planning a Stay in China
- How long does multiple myeloma treatment take? Cycles, maintenance and time in China
- How long does multiple sclerosis treatment last? Dosing schedules, review and stopping decisions
- How Long Does Parkinson’s Treatment Take? Medication Changes, DBS and Planning a Visit to China
- How Long Does Sickle Cell Treatment Take? Medicines, Transfusions, Recovery, and Travel Planning
- How Long Does Stroke Rehabilitation Take? Connecting Hospital, Outpatient and Home Care
- How long does T-cell lymphoma treatment take? Planning cycles, assessment, transplantation and travel
- How long does thalassemia treatment take? Transfusion cycles, medication assessment, and time needed in China
- Inpatient vs Outpatient Rehabilitation in China
- Integrative Supportive Care During Cancer Treatment in China
- Is Surgery Needed After Ischemic Stroke? Emergency, Preventive and Rehabilitation Procedures
- IVF Treatment in China: A Practical Guide for International Patients
- Joint Preservation Treatments: Questions to Ask Before Surgery
- Knee Replacement in China: A Patient Planning Guide
- Managing adverse effects of multiple sclerosis treatment: symptoms, tests and timely help
- Managing GVHD treatment side effects: symptoms, monitoring, and continuity of care
- Managing Mantle Cell Lymphoma Treatment Side Effects: Fever, Bleeding, Targeted Therapy, and CAR-T Monitoring
- Managing multiple myeloma treatment side effects: urgent symptoms and continuing care
- Managing T-cell lymphoma treatment side effects: when to seek help and what to record at home
- Managing thalassemia treatment side effects: what to report, when to seek help, and how to prepare
- Medication for drug-resistant epilepsy: choosing a regimen, checking newer drugs and planning monitoring
- Medicines During Stroke Rehabilitation: Prevention, Symptom Relief and Evidence Limits
- Medicines for aplastic anemia: understanding ATG, cyclosporine, and eltrombopag
- Medicines for follicular lymphoma: understanding the regimen, treatment line and monitoring
- Medicines for GVHD: Understanding Steroids, Ruxolitinib, Belumosudil and Later Treatment Options
- Medicines for Hodgkin lymphoma: understanding chemotherapy, CD30 treatment, and PD-1 therapy
- Medicines for mantle cell lymphoma: Chinese indications, BTK inhibitors and newer treatment options
- Medicines for multiple sclerosis: DMT options, monitoring, and planned transitions
- Medicines for T-cell lymphoma: indications, monitoring and treatment at home
- Multidisciplinary Cancer Care: How Tumor Boards Guide Treatment
- Multiple myeloma medicines: understanding the prescription and arranging treatment in China
- Multiple myeloma treatment: protecting organs while planning long-term control
- Multiple sclerosis treatment: building a plan for attacks, progression, and everyday function
- Neurological Rehabilitation in China: Choosing the Right Program
- Oral and Maxillofacial Surgery in China: What Patients Should Know
- Orthodontic Treatment in China: Planning for Long-Term Follow-Up
- Parkinson’s disease medicines: levodopa, add-on treatments and continuous delivery
- Parkinson's Disease Treatment in China: A Plan Built Around Daily Function
- Parkinson’s treatment side effects: dizziness, hallucinations, dyskinesia and new symptoms
- Pathology Review Before Cancer Treatment in China
- Percutaneous Coronary Intervention and Stents: A Patient Guide
- Postoperative Rehabilitation in China: Building a Recovery Plan
- Procedures and surgery in multiple myeloma: sampling, cell collection, and skeletal stability
- Procedures for aplastic anemia: marrow sampling, vascular access, and transplantation
- Procedures for multiple sclerosis: plasma exchange, AHSCT, and preparation before treatment
- Procedures in follicular lymphoma: biopsy, venous access, marrow examination and cell collection
- Radiation and Device Interventions for Alzheimer’s: Focused Ultrasound, Magnetic Stimulation and Sensory Therapy
- Radiation and interventional procedures for multiple sclerosis: choosing a specific treatment target
- Radiation for DLBCL: localized disease, residual sites and symptom relief
- Radiation for follicular lymphoma: localized treatment, low-dose palliation and repeat irradiation
- Radiation Therapy for Mantle Cell Lymphoma: Local Control, Short Courses, and Planning Care in China
- Radiation therapy for multiple myeloma: treating painful lesions and protecting function
- Radiation Therapy in China: A Patient Guide
- Recognizing Sickle Cell Treatment Side Effects: Urgent Symptoms and Planned Review
- Recurrent Pain Despite Sickle Cell Treatment: Reassessment and Next Steps
- Rehabilitation After Ischemic Stroke: From Hospital Therapy to Everyday Life
- Relapse or inadequate response in multiple sclerosis: managing the episode and the next treatment decision
- Relapsed or refractory aplastic anemia: confirming the cause and planning second-line treatment
- Relapsed or refractory DLBCL: reassessment and the next treatment decision
- Relapsed or refractory follicular lymphoma: confirm what changed before choosing the next line
- Relapsed or Refractory Mantle Cell Lymphoma: Confirming Progression and Planning the Next Treatment
- Relapsed or refractory multiple myeloma: confirming progression and choosing the next treatment
- Scoliosis Treatment in China: Evaluation and Care Planning
- SEEG and focal ablation for drug-resistant epilepsy: how recording, radiofrequency treatment and laser therapy differ
- Sickle Cell Disease Treatment: Preventing Crises, Protecting Organs, and Considering Transformative Therapy
- Side effects of aplastic anemia treatment: what needs review and what needs urgent care
- Side effects of drug-resistant epilepsy treatment: recognizing changes and getting the right help
- Side effects of Hodgkin lymphoma treatment: urgent symptoms and problems to track
- Spine Surgery in China: How to Evaluate Your Options
- Sports Injury Treatment in China: From Imaging to Rehabilitation
- Starting care after a thalassemia diagnosis: planning the first stage of treatment
- Starting first-line treatment for multiple myeloma
- Starting GVHD Treatment: Local Care, Corticosteroids, and Early Reassessment
- Starting Treatment After a Sickle Cell Diagnosis: Hydroxyurea, Prevention, and the First Follow-up Plan
- Starting Treatment for Parkinson's Disease: What the First Prescription Should Achieve
- Stereotactic Body Radiotherapy (SBRT): A Patient Guide
- Stimulation, Local Injections and Brain–Computer Interfaces in Stroke Rehabilitation
- Stroke Rehabilitation in China: A Guide for Patients and Families
- Sudden Worsening or Gradual Decline During Stroke Rehabilitation: What Needs Assessment?
- Surgery and procedures in thalassemia: decisions about the spleen, gallbladder, and other interventions
- Surgery for Alzheimer’s Disease: Understanding Neck Procedures, Brain Stimulation and Other Operations
- Surgery with Sickle Cell Disease: Gallbladder, Spleen, Joint Procedures, and Perioperative Planning
- Targeted Cancer Therapy: Biomarker Testing and Treatment Planning
- Thalassemia medicines: understanding the purpose of a prescription and its monitoring plan
- The first treatment plan after drug-resistant epilepsy is recognized: agree on changes, monitoring, and referral
- Transfusion support in aplastic anemia: irradiated components, reactions, and iron burden
- Treating Alzheimer's Disease: A Plan for Symptoms, Disease Progression, and Everyday Life
- Treating Graft-Versus-Host Disease: Acute and Chronic GVHD Care in China
- Treating thalassemia: from carrier status, transfusion and chelation to transplantation and newer therapies
- Treatment for diffuse large B-cell lymphoma: building a complete plan
- Uterine Fibroid Treatment: Comparing Medical and Surgical Options
- What happens after relapsed or refractory T-cell lymphoma? Confirming change and planning the next line
- What to Expect at a Traditional Chinese Medicine Consultation
- When does T-cell lymphoma need radiotherapy? Purpose, treatment area and planning
- When GVHD Persists or Flares Again: Reassessment and Later Treatment Decisions
- When Hodgkin lymphoma returns or resists treatment: reassessment, salvage therapy, and transplantation
- When Parkinson’s symptoms worsen again: wearing-off, acute deterioration and next treatment steps
- When seizures return in drug-resistant epilepsy: medication review, postoperative recurrence and reassessment
- When thalassemia treatment seems insufficient: worsening anemia, increasing transfusions, and poor iron control
- Where T-cell lymphoma treatment begins: subtype, initial therapy, and care in China
- Why radiotherapy is sometimes used in thalassemia: extramedullary hematopoiesis and spinal cord compression
- Why Red Cell Exchange Is Used in Sickle Cell Disease: Urgent Treatment and Aftercare